Gamma-1 anti-human CD23 monoclonal antibodies
US6011138A · kind A · utility
32Cited by
2References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 20, 1997 |
| Grant date | Jan 4, 2000 |
| Priority date | — |
| Expiry date | Feb 20, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-human CD23 monoclonal antibodies containing human gamma 1 constant domains and therapeutic uses are provided. These antibodies inhibit IL-4 induced IgE production by B-cells significantly greater than antibodies containing other constant domains.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.